Chandra Bhagat Pharma Limited (CBPL.BO)
INR 65.0
(0.0%)
INR 65.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 61.75 Million | 52.64 Million | 123.98 Million | 83.28 Million | -74.13 Million | 40.54 Million |
| Net Income | 15.3 Million | 9.05 Million | 7.96 Million | 1.89 Million | 3.14 Million | 6.88 Million |
| Depreciation & Amortization | 4.87 Million | 1.1 Million | 378 Thousand | 335 Thousand | 319.17 Thousand | 515.6 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -76.27 Million | 17.11 Million | 185.63 Million | 43.12 Million | 66.85 Million | -164.61 Million |
| Other non-cash items | 117.85 Million | 25.36 Million | -69.99 Million | 37.92 Million | -144.44 Million | 197.75 Million |
| Investing Cash Flow | -18.52 Million | -590 Thousand | 854 Thousand | 1.18 Million | 501.92 Thousand | -3.98 Million |
| Investments in PPE | -22.81 Million | -3.68 Million | -998 Thousand | -203 Thousand | -38.07 Thousand | -60.86 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.29 Million | 3.09 Million | 1.85 Million | 1.38 Million | 540 Thousand | -3.92 Million |
| Financing Cash Flow | -57.98 Million | -44.46 Million | -96.23 Million | -64.24 Million | 69.37 Million | -37.32 Million |
| Debt repayment | -44.07 Million | -15.79 Million | -52.98 Million | -19.57 Million | -9.3 Million | -50.4 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.9 Million | -28.67 Million | -43.25 Million | -44.67 Million | 78.67 Million | 13.08 Million |
| Accounts receivables | -312.61 Million | 68.18 Million | 4.13 Million | -13.88 Million | 122.68 Million | -84.33 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 204 Million | 50.79 Million | 9.82 Million | 87.63 Million | 110 Thousand | -112.76 Million |
| Other working capital | 32.33 Million | -101.85 Million | 171.66 Million | -30.62 Million | -55.93 Million | 32.48 Million |
| Cash at beginning of period | 64.39 Million | 56.81 Million | 28.21 Million | 524.37 Thousand | 4.77 Million | 5.54 Million |
| Cash at end of period | 49.64 Million | 64.39 Million | 56.81 Million | 28.21 Million | 524.37 Thousand | 4.77 Million |
| Capital Expenditure | -22.81 Million | -3.68 Million | -998 Thousand | -203 Thousand | -38.07 Thousand | -60.86 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.75 Million | 7.58 Million | 28.6 Million | 27.68 Million | -4.25 Million | -763.16 Thousand |
| Free Cash Flow | 38.93 Million | 48.95 Million | 122.98 Million | 83.08 Million | -74.16 Million | 40.48 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2022 FY | 2023 Q1 | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.17 Million | 3.17 Million | 9.05 Million | 2.68 Million | 2.68 Million | 1.84 Million |
| Depreciation & Amortization | 746.5 Thousand | 746.5 Thousand | 1.1 Million | 305.5 Thousand | 305.5 Thousand | 248.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -54.85 Million | -54.85 Million | 17.11 Million | 73.32 Million | 73.32 Million | -64.77 Million |
| Other non-cash items | 43.88 Million | 43.88 Million | 25.36 Million | -30.01 Million | -30.01 Million | 42.69 Million |
| Investing Cash Flow | -8.24 Million | -8.24 Million | -589 Thousand | 829.5 Thousand | 829.5 Thousand | -1.12 Million |
| Investments in PPE | -5.08 Million | -5.08 Million | -3.68 Million | -500 Thousand | -500 Thousand | -1.34 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.15 Million | -3.15 Million | 3.09 Million | 1.32 Million | 1.32 Million | 218.5 Thousand |
| Financing Cash Flow | -12.67 Million | -12.67 Million | -44.46 Million | -19.7 Million | -19.7 Million | -2.53 Million |
| Debt repayment | - | - | -15.79 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.67 Million | -12.67 Million | -28.67 Million | -19.7 Million | -19.7 Million | -2.53 Million |
| Accounts receivables | -90.81 Million | -90.81 Million | 68.18 Million | 56.25 Million | 56.25 Million | -22.16 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 52.57 Million | 52.57 Million | 50.79 Million | 16.34 Million | 16.34 Million | 9.05 Million |
| Other working capital | -16.61 Million | -16.61 Million | -101.85 Million | 729.5 Thousand | 729.5 Thousand | -51.65 Million |
| Cash at beginning of period | - | - | 56.81 Million | - | - | - |
| Cash at end of period | -27.97 Million | -27.97 Million | 64.39 Million | 27.43 Million | 27.43 Million | -23.63 Million |
| Capital Expenditure | -5.08 Million | -5.08 Million | -3.68 Million | -500 Thousand | -500 Thousand | -1.34 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -27.97 Million | -27.97 Million | 7.58 Million | 27.43 Million | 27.43 Million | -23.63 Million |
| Free Cash Flow | -12.14 Million | -12.14 Million | 48.95 Million | 45.8 Million | 45.8 Million | -21.32 Million |
INTECCAP
BJ
MTC
FLX
SHURB
FOYRK